Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine 5% cream versus Kligman combination cream for epidermal melasma
IRCT20181006041252N3Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cysteamine in melasma (2 arms), sponsored by Sabzevar University of Medical Sciences. Primary endpoints: Severity of the area involved in melasma and Derma Catch score. Started Oct 2018; status: completed.
02
Drugs
cysteamine
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20181006041252N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181006041252N3.